- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 13.594 ↓ -0.32%
[as on 6 March, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Kotak Healthcare Fund - Regular Plan - Growth Option and its peers as on 6 March, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| Kotak Healthcare Fund - Regular Plan - Growth Option | 2.27% | -0.32% | -1.03% | 4.35% | 0.65% | 11.72% | - | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 1.83% | -0.1% | -0.64% | 4.23% | -0.21% | 7.42% | 25.84% | 17.16% | 20.26% | 12.04% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -5.78% | -1.18% | -3.51% | -4.04% | -6.42% | 7.69% | 12.97% | 11.02% | 12.92% | 12.78% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -4.37% | -0.61% | -3.21% | -3.24% | -3.45% | 8.02% | 19.65% | 19.18% | 18.79% | 16.71% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.9% | -0.46% | -2.95% | 1.83% | 8.16% | 28.24% | 32.21% | 26.72% | 20.47% | 16.15% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -7.05% | -0.48% | -2.35% | -3.06% | -7.39% | -0.46% | 11.8% | 14.71% | 13.96% | 14.73% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 39.94% | -7.42% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|
| Returns | -0.22% | 3.71% | 3.61% | -1.9% | -1.64% | 2.65% | -0.35% | -2.39% | -4.69% | 7.38% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -1.77% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.71% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.29% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | SUNPHARMA (INE044A01036) | Pharmaceuticals and Biotechnology | 13.36% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 7.75% |
| JB Chemicals & Pharmaceuticals Ltd. | JBCHEPHARM (INE572A01036) | Pharmaceuticals and Biotechnology | 5.63% |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals and Biotechnology | 5.60% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals and Biotechnology | 4.68% |
| Fortis Healthcare India Ltd | FORTIS (INE061F01013) | Healthcare Services | 4.25% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.23% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals and Biotechnology | 3.88% |
| Ami Organics Ltd | ACUTAAS (INE00FF01025) | Pharmaceuticals and Biotechnology | 3.23% |
| JUBILANT PHARMOVA LIMITED | JUBLPHARMA (INE700A01033) | Pharmaceuticals and Biotechnology | 3.20% |
| ASTER DM HEALTHCARE LTD | ASTERDM (INE914M01019) | Healthcare Services | 3.03% |
| KRISHNA INSTITUTE OF MEDICAL | KIMS (INE967H01025) | Healthcare Services | 3.00% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals and Biotechnology | 2.81% |
| SAI LIFE SCIENCES LIMITED | SAILIFE (INE570L01029) | Pharmaceuticals and Biotechnology | 2.77% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals and Biotechnology | 2.52% |
| ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals and Biotechnology | 2.51% |
| Dr.Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals and Biotechnology | 2.49% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals and Biotechnology | 2.48% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals and Biotechnology | 2.39% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals and Biotechnology | 2.31% |
| Glenmark Pharmaceuticals Ltd | GLENMARK (INE935A01035) | Pharmaceuticals and Biotechnology | 2.24% |
| LAXMI DENTAL LIMITED | LAXMIDENTL (INE0WO601020) | Healthcare Equipment and Supplies | 1.96% |
| Marksans Pharma Ltd | MARKSANS (INE750C01026) | Pharmaceuticals and Biotechnology | 1.89% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals and Biotechnology | 1.62% |
| INNOVA CAPTABS LTD | INNOVACAP (INE0DUT01020) | Pharmaceuticals and Biotechnology | 1.62% |
| Krsnaa Diagnostics Ltd | KRSNAA (INE08LI01020) | Healthcare Services | 1.61% |
| ORCHID PHARMA LIMITED | ORCHPHARMA (INE191A01027) | Pharmaceuticals and Biotechnology | 1.51% |
| YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | YATHARTH (INE0JO301016) | Healthcare Services | 1.49% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 1.33% |
| RUBICON RESEARCH LIMITED | RUBICON (INE506V01022) | Pharmaceuticals and Biotechnology | 1.32% |
Portfolio data is as on date 31 October, 2025
NAV history
Kotak Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 6 March, 2026 | 13.594 |
| 5 March, 2026 | 13.638 |
| 4 March, 2026 | 13.44 |
| 2 March, 2026 | 13.671 |
| 27 February, 2026 | 13.735 |
| 26 February, 2026 | 13.877 |
| 25 February, 2026 | 13.721 |
| 24 February, 2026 | 13.577 |
| 23 February, 2026 | 13.6 |
| 20 February, 2026 | 13.47 |
| 19 February, 2026 | 13.455 |
| 18 February, 2026 | 13.509 |
| 17 February, 2026 | 13.463 |
| 16 February, 2026 | 13.377 |
| 13 February, 2026 | 13.291 |
| 12 February, 2026 | 13.456 |
| 11 February, 2026 | 13.454 |
| 10 February, 2026 | 13.313 |
| 9 February, 2026 | 13.255 |
| 6 February, 2026 | 13.027 |
| 5 February, 2026 | 13.075 |
| 4 February, 2026 | 13.055 |
| 3 February, 2026 | 13.09 |
| 2 February, 2026 | 12.669 |
| 30 January, 2026 | 12.731 |
| 29 January, 2026 | 12.593 |
| 28 January, 2026 | 12.667 |
| 27 January, 2026 | 12.634 |
| 23 January, 2026 | 12.6 |
| 22 January, 2026 | 12.745 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Kotak Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of Kotak Healthcare Fund - Regular Plan - Growth Option is 13.594 as on 6 March, 2026.
What are YTD (year to date) returns of Kotak Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of Kotak Healthcare Fund - Regular Plan - Growth Option are 2.27% as on 6 March, 2026.
What are 1 year returns of Kotak Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of Kotak Healthcare Fund - Regular Plan - Growth Option are 11.72% as on 6 March, 2026.